XRAY
Get informed when a big investor buys or sells
+ FollowUndervalued by 66.1% based on the discounted cash flow analysis.
| Market cap | $2.10 Billion |
|---|---|
| Enterprise Value | $4.20 Billion |
| Dividend Yield | $0.64 (3.06%) |
| Earnings per Share | $-3 |
| Beta | 0.85 |
| Outstanding Shares | 199,700,000 |
| P/E Ratio | -3.82 |
|---|---|
| PEG | 2.09 |
| Price to Sales | 0.58 |
| Price to Book Ratio | 1.74 |
| Enterprise Value to Revenue | 1.15 |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.56 |
| Debt to Equity | 1.74 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7657▲ 10.39% |
|---|---|
| Total Calls | 509,831▼ 41.37% |
| Total Puts | 390,400▼ 32.16% |
Holdings and activity of institutional investors.
| Ownership % | 115.45%▲ 8.92% |
|---|---|
| Total Invested | $2.65B▲ 7.17% |
| Investors Holding | 386▼ 12.00% |
No data